Andrew Aromando - Apr 28, 2023 Form 3 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role
Chief Operating Officer
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Andrew Aromando
Stock symbol
AMAM
Transactions as of
Apr 28, 2023
Transactions value $
$0
Form type
3
Date filed
5/5/2023, 04:05 PM
Next filing
Jul 7, 2023

No securities are beneficially owned.

Remarks:

See Exhibit 24 for power of attorney.